Biogen (BIIB) Minority Interest (2009 - 2023)

Biogen has reported Minority Interest for 15 years, with the latest figure at -$4.1 million in Q3 2023.

• On a quarterly basis, Minority Interest rose 52.87% year-over-year to -$4.1 million in Q3 2023; TTM through Sep 2023 was -$4.1 million, a 52.87% increase from a year earlier, with the FY2022 full-year figure at -$9.5 million, down 114.96% from the prior year.
• Minority Interest was -$4.1 million for Q3 2023 at Biogen, up from -$6.4 million in the prior quarter.
• The five-year high for Minority Interest was $462.9 million in Q2 2021, with the low at -$21.6 million in Q1 2022.
• Average Minority Interest over 5 years is $42.8 million, with a median of -$8.7 million recorded in 2022.
• The sharpest annual moves came in 2020 and 2021: Minority Interest slumped 375.61% in 2020, then surged 3327.14% in 2021.
• Over 5 years, Minority Interest stood at -$4.1 million in 2019, then sank by 246.34% to -$14.2 million in 2020, then surged by 547.18% to $63.5 million in 2021, then slumped by 114.96% to -$9.5 million in 2022, then soared by 56.84% to -$4.1 million in 2023.
• The last three Minority Interest figures came in at -$4.1 million (Q3 2023), -$6.4 million (Q2 2023), and -$9.6 million (Q1 2023), per Business Quant data.